Research location
Bergen
Hordaland, Norway
Advertisement
Research activity in Bergen
Hordaland, NorwayCureCurrent currently publishes aggregate city-level research activity for this location: 22 trials and 22 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bergen
22 linked trials · page 1 of 1A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)NCT07492680 · 2026-07-27 · 1 site observation
RECRUITING
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)NCT07100080 · 2025-11-05 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsNCT05503797 · 2023-02-21 · 1 site observation
RECRUITING
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)NCT04736706 · 2021-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)NCT04521621 · 2020-10-28 · 1 site observation
TERMINATED
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)NCT04221945 · 2020-05-12 · 1 site observation
COMPLETED
Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)NCT04220866 · 2020-03-04 · 1 site observation
COMPLETED
Effectiveness of a Team-based Follow-up Program in General Practice Among People With Chronic ConditionsNCT04076384 · 2019-08-19 · 1 site observation
COMPLETED
NAD-supplementation in Drug naïve Parkinson's DiseaseNCT03816020 · 2019-03-09 · 1 site observation
COMPLETED
ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer PatientsNCT03444181 · 2018-04-11 · 1 site observation
UNKNOWN
The Diabetes Patient-Reported Outcome Measures TrialNCT03471104 · 2018-01-15 · 1 site observation
WITHDRAWN
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)NCT03033511 · 2017-02-07 · 1 site observation
TERMINATED
The p53 Breast Cancer TrialNCT02965950 · 2016-10-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Low Calorie Diet in Morbidly Obese PatientsNCT02671279 · 2016-08-01 · 1 site observation
COMPLETED
Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory HallucinationsNCT02769507 · 2016-07-01 · 1 site observation
COMPLETED
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC TrialNCT02624973 · 2016-04-15 · 1 site observation
ACTIVE_NOT_RECRUITING
The Digital Breast Tomosynthesis Trial in BergenNCT02835625 · 2016-01-01 · 1 site observation
COMPLETED
Phase I Clinical Trial of Cryoimmunotherapy Against Prostate CancerNCT02423928 · 2015-05-01 · 1 site observation
COMPLETED
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT02106546 · 2014-04-10 · 1 site observation
COMPLETED
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerNCT02163694 · 2014-04-08 · 1 site observation
COMPLETED
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerNCT01506609 · 2012-01-23 · 1 site observation
COMPLETED
Childhood Obesity- Characteristics and TreatmentNCT00961740 · 2007-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.